CIR
NVO

Clear Investment Research’s Novo Nordisk NVO Stock Holding History

Clear Investment Research’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29
Closed -$1.07K – 162
2026
Q1 		$1.07K Buy
+29
New +$1.37K ﹤0.01% 216
2025
Q4 		– Sell
-29
Closed -$1.61K – 172
2025
Q3 		$1.61K Hold
29
– – ﹤0.01% 227
2025
Q2 		$2K Hold
29
– – ﹤0.01% 199
2025
Q1 		$2.01K Hold
29
– – ﹤0.01% 191
2024
Q4 		$2.5K Hold
29
– – ﹤0.01% 184
2024
Q3 		$3.45K Buy
+29
New +$3.87K ﹤0.01% 180

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Clear Investment Research's NVO Position: Q2 2026 in Review

Clear Investment Research sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 29 shares — an estimated $1.07K sold.

Clear Investment Research first reported a position in NVO in Q3 2024 and held it in 6 quarters. The position peaked at $3.45K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Clear Investment Research reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Clear Investment Research sold 29 Novo Nordisk shares in Q2 2026, an estimated $1.07K.
  • Clear Investment Research first reported a position in Novo Nordisk in Q3 2024 and held it in 6 quarters.
  • Clear Investment Research's Novo Nordisk position peaked at $3.45K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Clear Investment Research's 13F filing for Q2 2026, filed 11 Aug 2026.